NCT01588509 - Transition From Alendronate to Romosozumab (AMG 785) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 30, 2012

Primary Completion Date

November 21, 2012

Study Completion Date

November 21, 2012

Conditions

Osteoporosis

Interventions

DRUG

Romosozumab

Administered by subcutaneous injection

Trial Locations (9)

Research Site, West Haverstraw

Research Site, Wyomissing

Research Site, Bethesda

Research Site, Gainesville

Research Site, Tucson

Research Site, Albuquerque

Research Site, Walnut Creek

Research Site, Honolulu

Research Site, Seattle